Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

3.7%

4 terminated/withdrawn out of 109 trials

Success Rate

92.7%

+6.1% vs industry average

Late-Stage Pipeline

33%

36 trials in Phase 3/4

Results Transparency

14%

7 of 51 completed trials have results

Key Signals

7 recruiting7 with results

Enrollment Performance

Analytics

N/A

33(39.3%)

Phase 4

19(22.6%)

Phase 3

17(20.2%)

Phase 2

11(13.1%)

Phase 1

4(4.8%)

84Total

N/A(33)

Phase 4(19)

Phase 3(17)

Phase 2(11)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (109)

Showing 20 of 109 trials

NCT07835620Phase 4Completed

A Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of CANIUM Tab. in Acute Bronchitis Patients.

Role: collaborator

NCT06055478Not ApplicableCompleted

Effect of Suprascapular Nerve Block and Axillary Nerve Block After Arthroscopic Rotator Cuff Repair

Role: collaborator

NCT05507749Not ApplicableActive Not Recruiting

Cyroablation for Pulmonary Vein Isolation Alone in Patients With Early Persistent AF Assessed by Continuous Monitoring

Role: collaborator

NCT07769554Completed

Longitudinal Change in Depression Severity and Clinical Outcomes After Arthroscopic Rotator Cuff Repair

Role: collaborator

NCT06329141Phase 2Completed

A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients

Role: collaborator

NCT07497867Recruiting

Long-term Prospective Study of Korean CADASIL Patients

Role: collaborator

NCT02433795Phase 2Completed

Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)

Role: collaborator

NCT07479823Not ApplicableNot Yet Recruiting

A Text-Based Expressive Writing Program for Adolescents at Risk of Suicide

Role: lead

NCT04662112Phase 1Completed

Liposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic Adenocarcinoma

Role: collaborator

NCT04214990Phase 3Recruiting

Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients

Role: collaborator

NCT01461525Not ApplicableCompleted

Comparison of Sphincter Preservation Surgery and Abdominoperineal Resection (APR): Prospective Clinical Trial

Role: collaborator

NCT06688565Not ApplicableUnknown

A Prospective, Multi-center Registry to Evaluate Safety and Efficacy of Hativ® ELectrocardiogram Monitoring on Patients with Hemodialysis

Role: lead

NCT03993236Phase 4Completed

Study on Rosuvastatin+Ezetimibe and Rosuvastatin for LDL-C Goal in Patients With Recent Ischemic Stroke

Role: collaborator

NCT01917552Phase 3Recruiting

Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS

Role: collaborator

NCT01935778Phase 3Recruiting

Compare Adjuvant Chemotherapy of Docetaxel/Capecitabine/Oxliplatin Versus Capecitabine/Oxaliplatin in Advanced Gastric Cancer at Stage IIIb and IV(KCSG ST15-08): TRIUMPH

Role: collaborator

NCT03751761Phase 1Completed

GC 2nd Line Durvalumab(MEDI4736)/Tremelimumab Plus Paclitaxel Study

Role: collaborator

NCT06175169Not ApplicableUnknown

IA Model for Acute Appendicitis in CT

Role: lead

NCT02936232Recruiting

Severe Sepsis and Septic Shock Registry

Role: collaborator

NCT05768997Phase 3Unknown

High Dose IV Iron Plus ESA in Chemotherapy-induced Anemia

Role: lead

NCT05750797Unknown

The Nationwide Real-world Status of Oral Corticosteroid Use in Patients With Asthma

Role: collaborator